[1]
“Survival Rate of Gemcitabine Monotherapy after Prior Platinum-based Chemotherapy for Metastatic Bladder Cancer”, Cermin Dunia Kedokteran, vol. 49, no. 12, hlm. 693–701, Des 2022, doi: 10.55175/cdk.v49i12.329.